Virax Biolabs Group Limited(VRAX)

Biotechnology · Lanarkshire, SC

$1.92-0.48 (-20.00%)

Delayed quote: Oct 6, 2026, 3:50 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T19:54:26.684Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:54:26.684Z.

Quote observation: 2026-10-06T19:50:00.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 1.92
Unrounded diluted TTM EPS · period ending 2026-03-31: N/A

FMP input reference: 76ce780248c1f493ccbdb0751af92273333f1ee075484263629f1dd5eb2dbf7e

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

VRAX PE Ratio Metrics

PE RATIO

N/A

VRAX Competitors' PE Ratio

VRAX

Virax Biolabs Group Limited

Current

Market Cap

$358320.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NIKI

Niki BioSolutions, Inc.

vs VRAX

Market Cap

$401484.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SPRC

SciSparc Ltd.

vs VRAX

Market Cap

$246973.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XRTX

XORTX Therapeutics Inc.

vs VRAX

Market Cap

$479001.00

PE Ratio

N/A

TTM Avg

1.51

3Y Avg

1.33

5Y Avg

1.33

VIVS

VivoSim Labs, Inc.

vs VRAX

Market Cap

$527596.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HCWB

HCW Biologics Inc.

vs VRAX

Market Cap

$556226.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SLXN

Silexion Therapeutics Ltd.

vs VRAX

Market Cap

$109148.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PBM

Psyence Biomedical Ltd.

vs VRAX

Market Cap

$95475.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PRFX

PRF Technologies Ltd.

vs VRAX

Market Cap

$71053.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AKAN

Akanda Corp.

vs VRAX

Market Cap

$60340.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Virax Biolabs Group Limited (VRAX)	$358320.00	N/A	N/A	N/A	N/A
Niki BioSolutions, Inc. (NIKI)vs ›	$401484.00	N/A	N/A	N/A	N/A
SciSparc Ltd. (SPRC)vs ›	$246973.00	N/A	N/A	N/A	N/A
XORTX Therapeutics Inc. (XRTX)vs ›	$479001.00	N/A	1.51	1.33	1.33
VivoSim Labs, Inc. (VIVS)vs ›	$527596.00	N/A	N/A	N/A	N/A
HCW Biologics Inc. (HCWB)vs ›	$556226.00	N/A	N/A	N/A	N/A
Silexion Therapeutics Ltd. (SLXN)vs ›	$109148.00	N/A	N/A	N/A	N/A
Psyence Biomedical Ltd. (PBM)vs ›	$95475.00	N/A	N/A	N/A	N/A
PRF Technologies Ltd. (PRFX)vs ›	$71053.00	N/A	N/A	N/A	N/A
Akanda Corp. (AKAN)vs ›	$60340.00	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$1.92

Forward EPS (Est.)

$-6.00

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

VRAX PE Ratio Metrics

VRAX Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics